Jongkundang recently ranked among the top searched stocks for 2 days within the past month.
As of 9:30 AM on the 19th, Jongkundang is trading at 152,000 KRW, down 2.25% from the previous day. This represents a 22.05% decline compared to March 17. Jongkundang is known as a leading pharmaceutical company in the industry, focusing on therapeutics.
Over the past 5 days, individual investors have net purchased 87,469 shares, while foreigners and institutions have net sold 29,707 shares and 63,290 shares, respectively.
On March 18, Jongkundang was a market issue with the headline "Sharp Drop... Impact of COVID-19 Therapeutic Approval Failure."
※Source: AI Investment Assistant AI Rasero
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
